JP2023500011A5 - - Google Patents

Info

Publication number
JP2023500011A5
JP2023500011A5 JP2022507566A JP2022507566A JP2023500011A5 JP 2023500011 A5 JP2023500011 A5 JP 2023500011A5 JP 2022507566 A JP2022507566 A JP 2022507566A JP 2022507566 A JP2022507566 A JP 2022507566A JP 2023500011 A5 JP2023500011 A5 JP 2023500011A5
Authority
JP
Japan
Prior art keywords
seq
aav
itr
promoter
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022507566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023500011A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/072087 external-priority patent/WO2021028299A1/en
Publication of JP2023500011A publication Critical patent/JP2023500011A/ja
Publication of JP2023500011A5 publication Critical patent/JP2023500011A5/ja
Withdrawn legal-status Critical Current

Links

JP2022507566A 2019-08-12 2020-08-06 遺伝子療法によるパーキンソン病などのシヌクレイノパチーの治療に使用するためのウイルス粒子 Withdrawn JP2023500011A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382706.0 2019-08-12
EP19382706 2019-08-12
PCT/EP2020/072087 WO2021028299A1 (en) 2019-08-12 2020-08-06 Viral particles for use in treating synucleinopathies such as parkinson's diseases by gene therapy

Publications (2)

Publication Number Publication Date
JP2023500011A JP2023500011A (ja) 2023-01-04
JP2023500011A5 true JP2023500011A5 (https=) 2023-08-08

Family

ID=67659024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022507566A Withdrawn JP2023500011A (ja) 2019-08-12 2020-08-06 遺伝子療法によるパーキンソン病などのシヌクレイノパチーの治療に使用するためのウイルス粒子

Country Status (18)

Country Link
US (1) US20220298528A1 (https=)
EP (1) EP4013437A1 (https=)
JP (1) JP2023500011A (https=)
KR (1) KR20220099944A (https=)
CN (1) CN114786694A (https=)
AR (1) AR119609A1 (https=)
AU (1) AU2020328827A1 (https=)
BR (1) BR112022002615A2 (https=)
CA (1) CA3149844A1 (https=)
CL (1) CL2022000292A1 (https=)
CO (1) CO2022001192A2 (https=)
EC (1) ECSP22008949A (https=)
IL (1) IL290357A (https=)
MX (1) MX2022001676A (https=)
PE (1) PE20220601A1 (https=)
PH (1) PH12022550282A1 (https=)
TW (1) TW202120687A (https=)
WO (1) WO2021028299A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210148101A (ko) 2019-02-04 2021-12-07 프리라인 테라퓨틱스 리미티드 폴리뉴클레오티드
CN116390773A (zh) * 2020-08-06 2023-07-04 应用医学研究基金会 用于通过基因疗法治疗诸如阿尔茨海默病的Tau蛋白病的病毒颗粒
EP4511482A4 (en) * 2022-04-19 2026-03-18 Shanghai Vitalgen Biopharma Co Ltd Recombinant AAV vectors for the treatment of neurodegenerative disorders
CN118715316B (zh) * 2022-10-08 2025-09-19 凌意(杭州)生物科技有限公司 用于治疗GCase缺乏相关疾病的多核苷酸
WO2025063407A1 (ko) * 2023-09-22 2025-03-27 주식회사 스탠드업테라퓨티스 신규한 파킨슨 병 치료제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2985235A1 (en) * 2015-05-07 2016-11-10 Shire Human Genetic Therapies, Inc. Glucocerebrosidase gene therapy for parkinson's disease
AU2018346104B2 (en) * 2017-10-03 2023-07-27 Prevail Therapeutics, Inc. Gene therapies for lysosomal disorders
WO2019068854A1 (en) * 2017-10-06 2019-04-11 Ospedale San Raffaele S.R.L. GENE THERAPY OF NEURODEGENERATIVE DISEASES USING VAA VECTORS

Similar Documents

Publication Publication Date Title
JP2023500011A5 (https=)
JP7497247B2 (ja) 組換えアデノ随伴ウイルス9の髄腔内送達
Tal Adeno-associated virus-based vectors in gene therapy
CN113301956B (zh) 控制器官功能的基因治疗方法
JP2024513949A5 (https=)
TW201629225A (zh) 第九因子基因療法
EP2391388A1 (en) Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders
JP2024543211A5 (https=)
CN119487053A (zh) 具有优选脑、脊髓和/或心脏表达水平的选定腺相关病毒组合物
CN112029773B (zh) 编码bdnf的核酸及其应用
JP2020510433A5 (https=)
CN114126667A (zh) 使用糖苷水解酶的基因疗法载体向视网膜细胞的改进递送
TW202317769A (zh) 來自腺相關病毒血清型9(aav9)的分離的修飾衣殼蛋白vp1、基於其的衣殼和載體
RU2022102652A (ru) Вирусные частицы для применения в лечении синуклеинопатий, таких как болезнь паркинсона, методами генной терапии
Yang et al. 526. Intravasuclar Delivery of RAAVRH. 8 Generates Widespreading Transduction of Neuronal and Glial Cell Types in the Adult Mouse Central Nervous System
AU2024298945A1 (en) Brain-tropic aav mutant
KR20250097939A (ko) 투여 경로
EA048714B1 (ru) Выделенный модифицированный белок vp1 капсида аденоассоциированного вируса 9 серотипа (aav9), капсид и вектор на его основе
CN119894920A (zh) 用于靶向神经系统的新型aav衣壳及其用途
HK40004543B (en) Intrathecal delivery of recombinant adeno-associated virus 9
HK40004543A (en) Intrathecal delivery of recombinant adeno-associated virus 9
HK40042522A (en) Intrathecal delivery of recombinant adeno-associated virus 9